Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0V4KJ
|
|||
| Drug Name |
N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl-phenylcarbamate analog 1
|
|||
| Synonyms |
PMID28051882-Compound-10
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H24BrNO
|
|||
| Canonical SMILES |
C1CC2CC(CC1N2CC(C3=CC(=CC=C3)Br)O)C4=CC=CC=C4
|
|||
| InChI |
1S/C21H24BrNO/c22-18-8-4-7-16(11-18)21(24)14-23-19-9-10-20(23)13-17(12-19)15-5-2-1-3-6-15/h1-8,11,17,19-21,24H,9-10,12-14H2/t17?,19?,20?,21-/m0/s1
|
|||
| InChIKey |
OPZPEBWJFYVOEI-SLQSYFLNSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Sigma intracellular receptor 2 (TMEM97) | Target Info | Ligand | [1] |
| Target's Patent Info | Sigma intracellular receptor 2 (TMEM97) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Are sigma modulators an effective opportunity for cancer treatment A patent overview (1996-2016).Expert Opin Ther Pat. 2017 May;27(5):565-578. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.